NCT05359731View on ClinicalTrials.gov

Pharmacokinetic Analysis of Bupivacaine in the Presence and Absence of Perineural Dexamethasone in Axillary Blockade

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

April 17, 2023

Study Completion Date

April 24, 2023

Conditions
AnalgesiaAcute PainUpper Extremity Injury
Interventions
DRUG

Bupivacaine Hydrochloride

Patients will receive a total volume of 30 ml of bupivacaine 0.5% in an axillary block with a double puncture.

DRUG

Bupivacaine Hydrochloride with Dexamethasone

Patients will receive a total volume of 30 ml of bupivacaine 0.5% with Dexamethasone 4 mg in an axillary block with a double puncture.

Trial Locations (1)

Unknown

Hospital Clínico Universidad de Chile, Santiago

All Listed Sponsors
lead

University of Chile

OTHER